222 related articles for article (PubMed ID: 28503088)
21. Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in established and primary glioma cell lines.
Jaganathan J; Petit JH; Lazio BE; Singh SK; Chin LS
Neurosurg Focus; 2002 Sep; 13(3):ecp1. PubMed ID: 15844877
[TBL] [Abstract][Full Text] [Related]
22. Pathways involved in proliferating, senescent and immortalized keratinocyte cell death mediated by two different TRAIL preparations.
Qin JZ; Bacon PE; Chaturvedi V; Bonish B; Nickoloff BJ
Exp Dermatol; 2002 Dec; 11(6):573-83. PubMed ID: 12473065
[TBL] [Abstract][Full Text] [Related]
23. Immunotherapy with liposome-bound TRAIL overcomes partial protection to soluble TRAIL-induced apoptosis offered by down-regulation of Bim in leukemic cells.
De Miguel D; Gallego-Lleyda A; Galan-Malo P; Rodriguez-Vigil C; Marzo I; Anel A; Martinez-Lostao L
Clin Transl Oncol; 2015 Aug; 17(8):657-67. PubMed ID: 25967100
[TBL] [Abstract][Full Text] [Related]
24. Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy.
Dai X; Zhang J; Arfuso F; Chinnathambi A; Zayed ME; Alharbi SA; Kumar AP; Ahn KS; Sethi G
Exp Biol Med (Maywood); 2015 Jun; 240(6):760-73. PubMed ID: 25854879
[TBL] [Abstract][Full Text] [Related]
25. Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complex.
Izeradjene K; Douglas L; Delaney AB; Houghton JA
Cancer Res; 2004 Nov; 64(21):8036-44. PubMed ID: 15520213
[TBL] [Abstract][Full Text] [Related]
26. Identification of a novel pro-apoptotic role of NF-κB in the regulation of TRAIL- and CD95-mediated apoptosis of glioblastoma cells.
Jennewein C; Karl S; Baumann B; Micheau O; Debatin KM; Fulda S
Oncogene; 2012 Mar; 31(11):1468-74. PubMed ID: 21822306
[TBL] [Abstract][Full Text] [Related]
27. Effect of the XIAP inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer cells.
Mori T; Doi R; Kida A; Nagai K; Kami K; Ito D; Toyoda E; Kawaguchi Y; Uemoto S
J Surg Res; 2007 Oct; 142(2):281-6. PubMed ID: 17640673
[TBL] [Abstract][Full Text] [Related]
28. Pro-apoptotic signaling induced by Retinoic acid and dsRNA is under the control of Interferon Regulatory Factor-3 in breast cancer cells.
Bernardo AR; Cosgaya JM; Aranda A; Jiménez-Lara AM
Apoptosis; 2017 Jul; 22(7):920-932. PubMed ID: 28409399
[TBL] [Abstract][Full Text] [Related]
29. TNF-related apoptosis-inducing ligand (TRAIL): a potential candidate for combined treatment of hematological malignancies.
Secchiero P; Vaccarezza M; Gonelli A; Zauli G
Curr Pharm Des; 2004; 10(29):3673-81. PubMed ID: 15579063
[TBL] [Abstract][Full Text] [Related]
30. The TRAIL of oncogenes to apoptosis.
Oikonomou E; Pintzas A
Biofactors; 2013; 39(4):343-54. PubMed ID: 23813857
[TBL] [Abstract][Full Text] [Related]
31. Low-dose UV-radiation sensitizes keratinocytes to TRAIL-induced apoptosis.
Qin JZ; Bacon P; Panella J; Sitailo LA; Denning MF; Nickoloff BJ
J Cell Physiol; 2004 Jul; 200(1):155-66. PubMed ID: 15137068
[TBL] [Abstract][Full Text] [Related]
32. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas apoptosis in Burkitt's lymphomas with loss of multiple pro-apoptotic proteins.
Hussain A; Doucet JP; Gutiérrez M; Ahmad M; Al-Hussein K; Capello D; Gaidano G; Bhatia K
Haematologica; 2003 Feb; 88(2):167-75. PubMed ID: 12604406
[TBL] [Abstract][Full Text] [Related]
33. Auriculasin sensitizes primary prostate cancer cells to TRAIL-mediated apoptosis through up-regulation of the DR5-dependent pathway.
Cho HD; Gu IA; Won YS; Moon KD; Park KH; Seo KI
Food Chem Toxicol; 2019 Apr; 126():223-232. PubMed ID: 30817944
[TBL] [Abstract][Full Text] [Related]
34. Paclitaxel enhances tumoricidal potential of TRAIL via inhibition of MAPK in resistant gastric cancer cells.
Li L; Wen XZ; Bu ZD; Cheng XJ; Xing XF; Wang XH; Zhang LH; Guo T; Du H; Hu Y; Fan B; Ji JF
Oncol Rep; 2016 May; 35(5):3009-17. PubMed ID: 26986870
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of resistance to TRAIL-induced apoptosis in cancer.
Zhang L; Fang B
Cancer Gene Ther; 2005 Mar; 12(3):228-37. PubMed ID: 15550937
[TBL] [Abstract][Full Text] [Related]
36. Sensitization of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant primary prostate cancer cells by isoegomaketone from Perilla frutescens.
Lee JH; Cho HD; Jeong IY; Lee MK; Seo KI
J Nat Prod; 2014 Nov; 77(11):2438-43. PubMed ID: 25320841
[TBL] [Abstract][Full Text] [Related]
37. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells.
He Q; Luo X; Huang Y; Sheikh MS
Oncogene; 2002 Sep; 21(39):6032-40. PubMed ID: 12203115
[TBL] [Abstract][Full Text] [Related]
38. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
Ray S; Almasan A
Cancer Res; 2003 Aug; 63(15):4713-23. PubMed ID: 12907654
[TBL] [Abstract][Full Text] [Related]
39. The TRAIL to cancer therapy: Hindrances and potential solutions.
Wong SHM; Kong WY; Fang CM; Loh HS; Chuah LH; Abdullah S; Ngai SC
Crit Rev Oncol Hematol; 2019 Nov; 143():81-94. PubMed ID: 31561055
[TBL] [Abstract][Full Text] [Related]
40. Ethanolic extract of Brazilian green propolis sensitizes prostate cancer cells to TRAIL-induced apoptosis.
Szliszka E; Zydowicz G; Janoszka B; Dobosz C; Kowalczyk-Ziomek G; Krol W
Int J Oncol; 2011 Apr; 38(4):941-53. PubMed ID: 21286663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]